Issue 10/2014
Content (10 Articles)
Current Opinion
Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following Its 20th Anniversary
Robin Gauld
Leading Article
Decision-Analytic Models: Current Methodological Challenges
J. Jaime Caro, Jörgen Möller
Leading Article
Reconceptualising the External Validity of Discrete Choice Experiments
Emily Lancsar, Joffre Swait
Practical Application
Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models
Paul Tappenden, James B. Chilcott
Review Article
Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Lymphocytic Leukaemia: A Review of Methods to Model Disease Outcomes and Estimate Utility
Kevin Marsh, Peng Xu, Panagiotis Orfanos, James Gordon, Ingolf Griebsch
Original Research Article
Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes
Zafar Zafari, Kristian Thorlund, J. Mark FitzGerald, Carlo A. Marra, Mohsen Sadatsafavi
Original Research Article
Cost–Utility Analysis of Chemotherapy Regimens in Elderly Patients with Stage III Colon Cancer
David R. Lairson, Rohan C. Parikh, Janice N. Cormier, Wenyaw Chan, Xianglin L. Du
Original Research Article
Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis
An Tran-Duy, Annelies Boonen, Wietske Kievit, Piet L. C. M. van Riel, Mart A. F. J. van de Laar, Johan L. Severens
Erratum
Erratum to: Modelling the Cost Effectiveness of Interventions for Osteoporosis: Issues to Consider
Matt D. Stevenson, Peter L. Selby
Open Access
Letter to the Editor
Comment on “Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following its 20th Anniversary”
Scott Metcalfe, Rachel Grocott, Dilky Rasiah